PharmForward by Sathguru

Timely & critical #insights - global #biopharma
Brought to you by @Sathgurumc
#CompetitiveIntelligence #Innovation #Deals #M&A #PharmaBusinessIntelligence

[PharmForward by Sathguru @PharmFwd]

US #FDA approves @SamsungBioepis #ranibizumab #lucentis #biosimilar - first #ophthalmology biosimilar. Launch expected post June-2022
#eyediseases #biosimilars #PharmForward #biopharma
https://t.co/RSawTlosZX

[PharmForward by Sathguru @PharmFwd]

Nabbind the second approval for #Xywav, @JazzPharma strengthens its position in the #sleepingdisorder market

#fdaapproved #CNS #PharmForward
https://t.co/WlsxNRyuhF

[Sathguru Management Consultants @sathgurumc]

The August issue of “Food Business Insights – Newsletter from Sathguru” focuses on frozen foods and covers growth opportunities for Indian frozen food industry, importance of food safety, and the emerging #technologies for #frozen food industry.
https://t.co/muM5F4E9Kr

[PharmForward by Sathguru @PharmFwd]

With focus on #mRNA platforms intensifying post-COVID, @sanofi bets on #TranslateBio mRNA platfrom with $3.2 Bn acquisition
https://t.co/mrHuNIxnKz
#biotech #biopharma #vaccines #covidvaccine #PharmForward

[PharmForward by Sathguru @PharmFwd]

High hopes for new #treatments for #neglectedtropicaldiseases - First all-oral treatment for #sleepingsickness received @US_FDA nod - @DNDi having steered all stages of development of #fexinidazole

#PharmForward #NTDs #Sanofi #beatNTDs #Healthcare
https://t.co/M5aTeMsZMt

[PharmForward by Sathguru @PharmFwd]

Critical milestone - @MylanNews and @Bioconlimited receive first interchangeable #biosimilar designation for #Semglee -another step towards affordable access to #insulin
#diabetes #FDA #PharmForward
https://t.co/Wit0QOU6N6

[PharmForward by Sathguru @PharmFwd]

French speciality #biopharma, @IpsenGroup gains global rights for #IRLAB’s investigational drug, #mesdopetam for treatment of patients with #Parkinsonsdisease experiencing levodopa-induced #dyskinesia.

#PharmForward #CNS #Parkinsons #Healthcare
https://t.co/zXg65UEAEc

[PharmForward by Sathguru @PharmFwd]

Strategic deals powering #biosimilar portfolios - #Intas Pharma acquires global rights for late-stage #Stelara #ustekinumab #biosimilar
#autoimmune #MeijiSeika #DongA #psoriasis #JnJ #Janssen #PharmForward

https://t.co/D416WulD5t

[PharmForward by Sathguru @PharmFwd]

Branching out therapeutic area focus - @novonordisk adds #cardiovascular pipeline with @ProthenaCorp #ATTR portfolio and business
#amyloid #biopharma #biotech #PharmForward
https://t.co/ME9LqzBazl

[PharmForward by Sathguru @PharmFwd]

The @US_FDA issued an EUA for @genentech #arthritis drug, #actemra (#tocilizumab) based on four #clinicaltrials , demonstrated reduction in risk of death and duration of hospital stay.

#PharmForward #Roche #COVID19 #Mab #healthcare #Pharma
https://t.co/PlE7wf4IYT

[PharmForward by Sathguru @PharmFwd]

Multinational retail corporation @Walmart, partner with @novonordisk to roll out rapid acting analog #insulin, #ReliOn #NovoLog - Priced at much lower rate, intending reduce economic burden for #diabetes patients.

#PharmForward #InsulinAspart #biopharma
https://t.co/oGpXpw5Y3I

[PharmForward by Sathguru @PharmFwd]

Leveraging extensive global #generics front and distribution networks - @TevaUSA pens second commercialization deal for #Biosimilars - #StrategicPartnerships to enter this maturing market.

#PharmForward #Lucentis #ranibizumab #Biopharma #PharmDeals
https://t.co/y3eWOFZrme

[PharmForward by Sathguru @PharmFwd]

Commercial stage #biopharma @MorphoSys forges two deals, to gain a foothold in #hematology & #oncology market - #acquisition of #ConstellationPharma and #RoyaltyPharma #funding partnership supporting the firm.

#PharmForward #PharmaDeals #pharma
https://t.co/1m523UJL1T

[PharmForward by Sathguru @PharmFwd]

Consolidation in #patientdata #healthdata - @CioxHealth and @DatavantHQ @Roivant join forces to create mega #healthdata ecosystem; to aid in data driven #research #clinical decision making
https://t.co/ejF591pyft

[PharmForward by Sathguru @PharmFwd]

Cos seeking growth opportunities in #diagnostics and #preventivemedicine - @novoholdings acquires @TheBBIGroup to dive into the segment
#PharmForward #immunoassay #diagnosticservices
https://t.co/RbVo4cRYXr

[PharmForward by Sathguru @PharmFwd]

Progress in #AlzheimersDisease - @biogen snares accelerated #FDA approval for #aducanumab #Aduhelm , targets underlying cause #amyloid plaque and reduces cognitive decline
#neuroscience #CNS #noveldrug #biologic #PharmForward
https://t.co/NTaPD3meGZ

[PharmForward by Sathguru @PharmFwd]

Moving beyond #biosimilars #biobetters - @CelltrionDream and Mirrae Asset invest in #antibodydrugconjugate developer @IksudaT , expands #novel #oncology pipeline

#biopharma #biologic #PharmForward #cancer

https://t.co/0PpW2c5r1H

[PharmForward by Sathguru @PharmFwd]

Third largest #biotech #IPO of the year - @centessa with its new #Pharmaceutical #RnD Model brought in IPO of USD 330 Million.

#PharmForward #ipo2021 #DrugDiscovery #pharma #competitiveintelligence
https://t.co/yX0p7ZF2wg

[PharmForward by Sathguru @PharmFwd]

Notable development in #CARTcell Therapies, an untapped space in #India - @drreddys makes its entry and begins development of assets in India, for India.

#PharmForward #Pregene #PRG1801 #oncology #DrReddys #biotech #celltherapy
https://t.co/W6iccyPNrO

[PharmForward by Sathguru @PharmFwd]

Establishing a global powerhouse in #orphan and #raredisease - @AmrytPharmaPlc acquires @chiasmapharma ; bolsters commercial and development pipeline
https://t.co/rnbn8idesY